Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000721748-16-001321
Filing Date
2016-05-23
Accepted
2016-05-23 17:19:31
Documents
33
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 kays10q052316.htm 10-Q 208111
2 kays10q052316ex31_1.htm EX-31.1 9722
3 kays10q052316ex32_1.htm EX-32.1 4449
  Complete submission text file 0000721748-16-001321.txt   1584723

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE afai-20160331.xml EX-101.INS 292736
5 XBRL SCHEMA FILE afai-20160331.xsd EX-101.SCH 17024
6 XBRL CALCULATION FILE afai-20160331_cal.xml EX-101.CAL 36957
7 XBRL DEFINITION FILE afai-20160331_def.xml EX-101.DEF 14549
8 XBRL LABEL FILE afai-20160331_lab.xml EX-101.LAB 141341
9 XBRL PRESENTATION FILE afai-20160331_pre.xml EX-101.PRE 90047
Mailing Address 305 SOUTH ANDREWS AVENUE SUITE 209 FORT LAUDERDALE FL 33301
Business Address 305 SOUTH ANDREWS AVENUE SUITE 209 FORT LAUDERDALE FL 33301 954-5347895
Kaya Holdings, Inc. (Filer) CIK: 0001530746 (see all company filings)

EIN.: 900898007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 333-177532 | Film No.: 161670067
SIC: 2834 Pharmaceutical Preparations